The Middle East and Africa soft tissue repair market is expected to grow from US$ 855.51 million in 2021 to US$ 1,224.11 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.
Sports medicine has received importance with the development of new products for treating various sports injuries, growing awareness about sports injuries, and increasing expenditure on sports medicine. A growing number of sport medicine centers in developed and developing economies has encouraged developments in diagnostic and treatment services for several soft tissue injuries. In developed countries of the region, sports medicine research centers primarily focus on preventive care and early diagnosis of sports injuries. Key players in the soft tissue repair markets are engaged in extensive research and development activities. Also, the rising interest of athletes and government bodies would pave the way for high-quality randomized control trials and encourage new products in the market.As the number of COVID-19 cases increase in the Middle East and Africa, many countries are grappling with controlling the spread of the virus. Various segments of the medical industry, such as soft tissue repair, are suffering losses during the COVID-19 pandemic due to limited production and supply chain facilities. The pandemic is affecting the business operations of the key players operating in the regional market in a negative manner.. The immediate economic impact reduced commodities exports, and restricted access to the Middle East and Africa capital markets. Iran is one of the worst hit countries by the pandemic. The country is struggling to control the crisis due to limited healthcare supplies owing to imposed US sanctions on the country. Research activities have been slowed down due to the shutdown of research centers, lack of healthcare facilities, and increasing number of cases. If the situation prolonged, the soft tissue repair market will be heavily affected, and growth will be slowed down.

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Middle East and Africa Soft Tissue Repair Market Segmentation
- Middle East and Africa Soft Tissue Repair Market – By Product
- Fixation Instruments
- Tissue Mesh/Patch
- Middle East and Africa Soft Tissue Repair Market – By Application
- Orthopedic Repair
- Hernia Repair
- Breast Reconstruction
- Pelvic and Vaginal Prolapse Repair
- Skin Repair
- Dental Repair
- Dural Repair
- Others
- Middle East and Africa Soft Tissue Repair Market – By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa
Middle East and Africa Soft Tissue Repair Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 855.51 Million |
Market Size by 2028 | US$ 1,224.11 Million |
Global CAGR (2021 - 2028) | 5.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset


- GMP Cytokines Market
- Clinical Trial Supplies Market
- Blood Collection Devices Market
- Rare Neurological Disease Treatment Market
- Lymphedema Treatment Market
- Educational Furniture Market
- Analog-to-Digital Converter Market
- Workwear Market
- Cosmetic Bioactive Ingredients Market
- Health Economics and Outcome Research (HEOR) Services Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Smith & Nephew
- DePuy Synthes
- Arthrex, Inc.
- Medtronic
- Integra Life Sciences Corporation
- Stryker Corporation
- BD
- Organogenesis Inc.
- Allergan Plc.
- B. Braun Melsungen AG
- DSM
- Baxter International Inc.